CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −155 | $590.69 | $92K | 41,913 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $591.64 | $166K | 41,633 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $592.98 | $142K | 41,393 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $594.11 | $261K | 40,953 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $595.29 | $119K | 40,753 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $596.11 | $143K | 40,513 |
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 21,500 | ||
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Gift · Stock Option 10b5-1 | −349,192 | 349,192 | ||
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Gift · Stock Options 10b5-1 | +349,192 | 349,192 | ||
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Gift · Stock Options 10b5-1 | −500,000 | 0 | ||
| 2026-04-01 | ROTHBLATT MARTINE A Chairperson & CEO | Gift · Stock Options 10b5-1 | +500,000 | 500,000 | ||
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $574.55 | $46K | 49,933 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $577.54 | $92K | 49,773 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $580.08 | $139K | 49,533 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −503 | $581.10 | $292K | 49,030 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −805 | $582.19 | $469K | 48,225 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,391 | $583.08 | $811K | 46,834 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −980 | $584.04 | $572K | 45,854 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,161 | $585.00 | $679K | 44,693 |
Page 134 of 171 · 3,408 trades